All Sections
action:article | category:AGGREGATION | adString:AGGREGATION | zoneID:2
Welcome guest, you have 3 views left. | Register | Sign In

NH Angle is a news and information aggregation by staff and audience of the New Hampshire Union Leader, The Goffstown News, The Bedford Bulletin, The Hooksett Banner and The Salem Observer. Share a news link here or comment on this item below.

New hepatitis C wonder drug shakes up the health care industry with remarkable success and $1,000/pill price

In December 2013, Sovaldi won approval from the U.S. Food and Drug Administration, and Roth, of San Rafael, Calif., was placed on a 24-week treatment regimen. The cost: $168,000, or an eye-popping $1,000 per pill. The company says Sovaldi’s price reflects its 90 percent-plus cure rate for hepatitis C and the savings that produces by cutting patients’ long-term treatment costs, which can include hospitalizations, surgeries and even liver transplants.

CLICK TO VIEW THE SOURCE MATERIAL


Comments


To improve the chance of seeing your comment posted here or published in the New Hampshire Union Leader:

  • Identify yourself. Accounts using fake or incomplete names are suspended regardless of the quality of posts.
  • Say something new, stay on topic, keep it short.
  • Links to outside URLs are discouraged, if used they should be on topic.
  • Avoid comments in bad taste, write well, avoid using all capital letters
  • Don't cite facts about individuals or businesses without providing a means to verify the claim
  • If you see an objectionable comment please click the "Report Abuse" button and be sure to tell us why.

Note: Comments are the opinion of the respective poster and not of the publisher.

Be the first to comment.

Post a comment


You must sign in before you can post comments. If you are experiencing issues with your account please e-mail abuse@unionleader.com.


Most Popular

action:article | category:AGGREGATION | adString:AGGREGATION | zoneID:88